Products for Research Use Only
RegisterLogin

CPX-351

CAT: 0013-GTR19194918-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19194918-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CPX-351 (Vyxeos) is a liposomal formulation co-encapsulating cytarabine and daunorubicin, designed for synergistic antitumor activity. It is widely used in acute myeloid leukemia (AML) research, with applications in both in vitro cytotoxicity assays and in vivo xenograft model studies to evaluate its efficacy and mechanism of action.
CAS Number
1256639-86-7
Product Name Alternative
CPX351, CPX-351, CPX 351, Daunonubicin/cytarabine, Cytarabine/daunonubicin, Vyxeos
Purity
98.95% (May vary between batches)
Smiles
O[C@@H]1[C@@H] (O[C@H] (CO) [C@H]1O) N2C (=O) N=C (N) C=C2.OC=1C2=C ([C@@H] (O[C@H]3C[C@H] (N) [C@H] (O) [C@H] (C) O3) C[C@@] (C (C) =O) (O) C2) C (O) =C4C1C (=O) C=5C (C4=O) =C (OC) C=CC5
Molecular Formula
C36H42N4O15
Molecular Weight
770.74
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR17968194Cpx Antibody
GTR18003108CPX Antibody
GTR17963217Cpx-1 Antibody
GTR19209000-01BMS-351
GTR19198624-01TNP-351
GTR19144533-01CPN-351
GTR19154197-01GNF-351
GTR19237971-01NADI-351
GTR19275680-01CRBN ligand-351
GTR19113267-01CPN-351 TFA

Alternative Products

CatalogName
T31088-01CPX-351
S5008-01Ciprofloxacin (CPX) hydrochloride
ABC-TC1282WEHI 3B/CPX
sc-221951Mn-cpx 3
HY-19095TNP-351
6448/25ML 351
T70847-01BMS-351
HY-131349-01CCR4-351
HY-P10473CPN-351
HY-164404-01NADI-351

Popular Products